Anstelle von Bananen und Tonnen von Kokain, die Verbindungen reichen bis nach Wall Street.

The European Union has announced plans to introduce new regulations targeting the production and distribution of synthetic cannabinoids, commonly known as “legal highs” or “banana tones,” which have gained popularity among young users due to their psychoactive effects. The proposed measures aim to close legal loopholes and prevent these substances from being sold under misleading labels such as “plant-based” or “natural.” According to officials, the initiative reflects growing concerns over public health risks and the potential for these products to be linked to broader financial networks, with some reports suggesting connections extending as far as Wall Street. The regulatory proposal was unveiled during a meeting of the EU’s executive body, the Commission, on July 18, 2026, in Brussels. It outlines a comprehensive strategy involving stricter labeling requirements, enhanced testing protocols, and increased penalties for manufacturers found to be supplying illegal substances disguised as legal products. The move comes after several member states reported a surge in emergency room visits related to synthetic cannabinoid intoxication, particularly among adolescents and young adults. Officials from the European Drug Policy Observatory noted that while synthetic cannabinoids were initially marketed as safer alternatives to traditional cannabis, they often contain highly potent compounds that can cause severe side effects, including hallucinations, rapid heart rate, and even psychosis. In recent months, authorities in countries such as Germany, France, and Italy have launched coordinated raids targeting online vendors selling these products, seizing thousands of packages and issuing fines against multiple businesses. The proposed legislation would require all products containing synthetic cannabinoids to undergo mandatory third-party safety assessments before being placed on the market. Additionally, it mandates that packaging include clear warnings about the dangers of misuse and the potential for addiction. A key component of the plan involves creating a centralized database of chemical compositions used in these products, enabling faster identification and tracking of illicit batches. Some stakeholders, however, have raised concerns about the impact of the new rules on legitimate herbal product manufacturers who rely on plant-based ingredients. Industry representatives argue that the current classification system is overly broad and could inadvertently penalize companies producing safe, legally compliant products. They have called for clearer definitions of what constitutes a “synthetic cannabinoid” and greater transparency in enforcement procedures. Meanwhile, law enforcement agencies continue to investigate alleged links between certain distributors of synthetic cannabinoids and international financial networks. Preliminary findings suggest that some operators may be using cryptocurrency transactions to evade detection, raising alarms about the potential for these substances to become part of a larger black-market economy. While no direct evidence of Wall Street involvement has been uncovered yet, officials warn that the situation warrants further scrutiny. In response to the proposed changes, consumer advocacy groups have expressed support, emphasizing the need for stronger oversight to protect vulnerable populations. Public health experts also welcome the move, noting that early intervention could significantly reduce long-term health consequences associated with chronic exposure to these substances. As the EU prepares to finalize the draft legislation, discussions are ongoing regarding how best to balance regulatory rigor with economic considerations.